Loading clinical trials...
Loading clinical trials...
The objective of this trial was to determine the efficacy and safety of linaclotide 72 ug administered once daily to patients with chronic idiopathic constipation (CIC). The primary efficacy parameter...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ironwood Pharmaceuticals, Inc.
Collaborators
NCT04838522 · Chronic Idiopathic Constipation (CIC)
NCT06736912 · Chronic Idiopathic Constipation
NCT03879239 · Chronic Idiopathic Constipation
NCT04804267 · Chronic Idiopathic Constipation
NCT02819297 · Constipation, Chronic Idiopathic Constipation, and more
Ironwood Investigational Site
Huntsville, Alabama
Ironwood Investigational Site
Phoenix, Arizona
Ironwood Investigational Site
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions